Anhui Anke Biotechnology (Group) (300009.SZ) Earnings Analysis
Anhui Anke Biotechnology (Group) (300009.SZ) next reports earnings on 2026-08-20. Trailing P/E 19.72.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 300009.SZ next report earnings?
| Next earnings date | 2026-08-20 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
300009.SZ earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-23 | 0.1 CNY | n/a | n/a | n/a |
| 2025-04-28 | 0.1278 CNY | n/a | n/a | n/a |
| 2024-10-24 | 0.1062 CNY | n/a | n/a | n/a |
300009.SZ valuation and analyst view
| Trailing P/E | 19.72 |
|---|---|
| Trailing EPS | 0.41536 CNY |
| Price / book | 2.89 |
| Dividend yield | 3.05% |
| Market cap | 13.80B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Anhui Anke Biotechnology (Group) (300009.SZ)'s next earnings date?
Anhui Anke Biotechnology (Group) is next scheduled to report on 2026-08-20.
Did 300009.SZ beat earnings last quarter?
Consensus estimate data was not available for 300009.SZ's 2026-04-23 report.
What is 300009.SZ's current P/E ratio and EPS?
300009.SZ trades at a trailing P/E of 19.72 on trailing EPS of 0.4153648083540927 CNY.
What do analysts rate 300009.SZ?
300009.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.